Impact of MTHFR C677T gene polymorphism and vitamins intake on homocysteine concentration in the Polish adult population

Kardiologia Polska

Volumn 69, Issue 12, 2011, Pages 1259-1264

  Waśkiewicz, Anna ^a   Piotrowski, Walerian ^a   Broda, Grazyna ^a   Sobczyk Kopcioł, Agnieszka ^b   Płoski, Rafał ^b  

^a INSTITUTE OF CARDIOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Folate; Homocysteine; MTHFR C677T

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; DNA; FOLIC ACID; HOMOCYSTEINE; METHIONINE; PYRIDOXINE; VITAMIN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; AGED; ALCOHOL CONSUMPTION; AMINO ACID BLOOD LEVEL; ARTICLE; COFFEE; DNA POLYMORPHISM; DRUG USE; FEMALE; GENE FREQUENCY; GENOTYPE; HEALTH SURVEY; HUMAN; MALE; POLAND; SAMPLING; SEX DIFFERENCE; SMOKING; VITAMIN INTAKE; CLINICAL TRIAL; GENETIC POLYMORPHISM; GENETICS; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; STATISTICAL MODEL;

ADULT; AGED; FEMALE; GENE FREQUENCY; GENOTYPE; HEALTH SURVEYS; HOMOCYSTEINE; HUMANS; LINEAR MODELS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLAND; POLYMORPHISM, GENETIC; VITAMINS;

EID: 84455175910     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Humphrey LL, Fu R, Rogers K, Freeman M, Helfand M. Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clin Proc, 2008; 83: 1203-1212.
2. Wald D, Law M, Morris J. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ, 2002; 325: 1202-1209.
3. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke. JAMA, 2002; 288: 2015-2022.
4. Naruszewicz M, Jankowska E, Zymliński R et al. Hyperhomocysteinemia in patients with symptomatic chronic heart failure: prevalence and prognostic importance - pilot study. Atherosclerosis, 2007; 194: 408-414. (Pubitemid 47513068)
5. Banecka-Majkutewicz Z, Ga̧secki D, Jakóbkiewicz-Banecka J, Banecki B, Wȩgrzyn G, Nyka W. Hiperhomocysteinemia - ważny czynnik ryzyka udaru mózgu. Udar Mózgu, 2005; 7: 61-65. (Pubitemid 43224270)
6. Graban A, Bednarska-Makaruk M, Bochyńska A, Lipczyńska- Łojkowska W, Ryglewicz D, Wehr H. Vascular and biochemical risk factors of vascular dementia after lacunar strokes (S-VaD) and after multiinfarcts in strategic areas (M-VaD). J Neurol Sci, 2009; 238: 116-118.
7. Refsum H, Smith D, Ueland PM et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem, 2004; 50: 3-32. (Pubitemid 38125696)
8. Cortese C, Motti C. MTHFR gene polymorphism, homocysteine and cardiovascular disease. Pub Health Nutr, 2001; 4 (2B): 493-497. (Pubitemid 32524571)
9. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG. MTHFR 677C-T polymorphism and risk of coronary heart disease. JAMA, 2002; 288: 2023-2031. (Pubitemid 35204693)
10. Dhonukshe-Rutten RA, de Vries JH, de Bree A, van der Put N, van Staveren WA, de Groot LC. Dietary intake and status of folate and vitamin B12 and their association with homocysteine and cardiovascular disease in European populations. Eur J Clin Nutr, 2009; 63: 18-30.
11. Ganji V, Kafai MR. Demographic, health, lifestyle, and blood vitamin determinants of serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr, 2003; 77: 826-383.
12. Rywik S, Kupsc W, Piotrowski W et al. Multi-center all-Polish health survey - WOBASZ Project. Methodological assumption and logistics. Pol Popul Rev, 2005; 27: 37-50.
13. Kostrzewa G, Broda G, Kurjata P, Piotrowski W, Ploski R. Effect of protein convertase subtilisin/kexin type 9 (PCSK9) 46L gene polymorphism on LDL cholesterol concentration in a Polish adult population. Molecular Gen Metab, 2008; 94: 259-262.
14. Czeizel E, Timar L, Botto L. Prevalence of methylenetetrahydrofolate reductase (MTHFR) gene polymorphism (C677T) in the Hungarian population. Orvosi Hetilap, 2001; 142: 1227-1229.
15. Zuntar I, Topić E, Vukosavić D et al. Croatian population data for the C677T polymorphism in methylenetetrahydrofolate reductase: frequencies in healthy and atherosclerotic study groups. Clin Chim Acta, 2003; 335: 95-100. (Pubitemid 37338313)
16. Adams M, Smith PD, Martin D, Thompson JR, Lodwick D, Samani NJ. Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction. Q J Med, 1996; 89: 437-444. (Pubitemid 26184329)
17. Gudnason V, Stansbie D, Scott J, Bowron A, Nicaud V, Humphries S. C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. EARS group. Atherosclerosis, 1998; 136: 347-354. (Pubitemid 28133424)
18. Motulsky AG. Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet, 1996; 58: 17-20.
19. Zhang L, Miyaki K, Araki J, Nakayama T, Muramatsu M. The relation between nicotinamide N-methyltransferase gene polymorphism and plasma homocysteine concentration in healthy Japanese men. Thromb Res, 2007; 121: 55-58. (Pubitemid 350025995)
20. Goracy I, Cyrylowski L, Kaczmarczyk M et al. C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of ischemic stroke in Polish subjects. J Appl Genet, 2009; 50: 63-67.
21. Girelli D, Friso S, Trabetti E et al. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. Blood, 1998; 91: 4158-4163. (Pubitemid 28261978)
22. Morita H, Taguchi J, Kurihara H at al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation, 1997; 95: 2032-2036. (Pubitemid 27184270)
23. Verhoef P, Kok FJ, Kluijtmans LA et al. The 677C->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis, 1997; 132: 105-113. (Pubitemid 27306745)
24. Waśkiewicz A, Sygnowska E, Broda G: Dietary intake of vitamin B6, B12 and folate and their association with homocysteine in adult Polish population - WOBASZ Project. Kardiol Pol, 2010; 68: 275-282.